Global evolution of inflammatory bowel disease across epidemiologic stagesLindsay Hracs, Shinji Okabayashi, Michael Buie et al.|Nature|2025Cited by 294
Real-world Effectiveness and Safety of Vedolizumab for the Treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab CohortNikolas Plevris, Charlie W. Lees, Cher Shiong Chuah et al.|Journal of Crohn s and Colitis|2019Cited by 51